For improving the understanding of the nuances of SARS-CoV-2 genome sequencing and its public health relevance in the context of the current pandemic, the Department of Biotechnology recently conducted a public webinar on the “Genome Sequencing of SARS-CoV-19″.
- The webinar aimed at demystifying the science behind mutations in the viral genome, viral genome sequencing, and public health implications of the mutations in the viral genome.
- A panel of experts from various reputed institutes & organizations discussed different aspects of genome sequencing and highlighted the importance of sequencing the Genome of SARS-CoV-19, and the work done by the Indian SARS-CoV-2 Genomics Consortium in ascertaining the presence of variants of SARS-CoV-2, establishing sentinel surveillance for early detection, and determining the genomic variants in the unusual events/trends.
About INDIAN SARS-COV-2 GENOMIC CONSORTIUM (INSACOG)
- In the backdrop of reports of emergence of variants of the SARS-CoV-2, in the world, the Government of India had established a national multi-agency consortium, Indian SARS-CoV-2 Genomic Consortium (INSACOG) in December 2020.
- It consists of ten laboratories of the Department of Biotechnology, Council of Scientific and Industrial Research (CSIR), Indian Council of Medical Research (ICMR) and Ministry of Health & Family Welfare (MoHF&W) with the overall aim of monitoring the genomic variations in the SARS-CoV-2 on a regular basis.
- Its overall aim is monitoring the genomic variations in the SARS-CoV-2 on a regular basis.
- The responsibility to correlate the clinical aspects and coordinate the collection of samples from states, for this purpose, was provided to National Centre for Disease Control (NCDC), MoHFW.
- INSACOG has a data repository at IGIB, New Delhi and NIBMG, Kalyani.